Allergy Therapeutics Cleared to Investigate Peanut Allergy Vaccine by FDA

 Allergy Therapeutics PLC said that it has received clearance for an investigational new drug application from the U.S. Food & Drug Administration for its peanut allergy vaccine.

The commercial biotechnology company specializing in allergy vaccines said this clearance paves the way for the first phase Protect trial, to be launched in the U.S.

The trial will begin later this year, Chief Executive Manuel Llobet said.

https://www.marketscreener.com/quote/stock/ALLERGY-THERAPEUTICS-PLC-4004878/news/Allergy-Therapeutics-Cleared-to-Investigate-Peanut-Allergy-Vaccine-by-FDA-37643117/